SCHEMBL3270107

SCHEMBL3270107

CC(C)(C)OC(=O)N1CCN(c2cc(-c3ccc(F)cc3)ncn2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 1/20 0.50
GPR119 Q8TDV5 2/20 0.49
CKS1B P61024 2/20 0.49
SKP1 P63208 2/20 0.49
SKP2 Q13309 2/20 0.49
GRIA1 P42261 1/20 0.48
TBK1 Q9UHD2 4/20 0.47
ITGB2 P05107 2/20 0.47
ICAM1 P05362 2/20 0.47
ITGAL P20701 2/20 0.47
KIT P10721 1/20 0.47
HRH4 Q9H3N8 1/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP1A2 P05177 1/20 0.45
GLA P06280 1/20 0.45
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
HSD17B10 Q99714 1/20 0.45
LRRK2 Q5S007 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3273530 0.89 CKS1B (0.62) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL3269829 0.88 CKS1B (0.52) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL3267984 0.86 FAAH (0.59) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL3268033 0.83 SMARCA2 (0.53) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL8515152 0.82 GPR119 (0.48) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL3268523 0.81 SMARCA2 (0.48) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL6788585 0.81 RET (0.55) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL27029576 0.79 CKS1B (0.54) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL30718193 0.79 CKS1B (0.54) MAP4K4GPR119CKS1BSKP1SKP2
SCHEMBL16333334 0.79 HRH3 (0.56) MAP4K4GPR119CKS1BSKP1SKP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101981010-A Amide compound TAKEDA PHARMACEUTICAL 2011-02-23 CN disclosed
US-20100234389-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-16 US disclosed
EP-2199282-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2010-06-23 EP disclosed
US-20090163508-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234389-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA MAP4K4 2554/4885GPR119 996/4885CKS1B 3175/4885
US-20090163508-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA MAP4K4 2554/4885GPR119 996/4885CKS1B 3175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.